inflammatory bowel diseases (IBD), including crohn's disease (CD) and ulcerative colitis (UC), are chronic idiopathic, relapsing and remitting inflammatory diseases that affect the gastrointestinal tract, causing significant morbidity and loss of quality of life in affected individuals [...].
Luiz-Ferreira, A., Stolfi, C. (2023). Special Issue “Drug Treatments for Inflammatory Bowel Diseases”. PHARMACEUTICALS, 17(1) [10.3390/ph17010059].
Special Issue “Drug Treatments for Inflammatory Bowel Diseases”
Carmine Stolfi
2023-01-01
Abstract
inflammatory bowel diseases (IBD), including crohn's disease (CD) and ulcerative colitis (UC), are chronic idiopathic, relapsing and remitting inflammatory diseases that affect the gastrointestinal tract, causing significant morbidity and loss of quality of life in affected individuals [...].File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
